Glassman Wealth Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-881
| Closed | -$119K | – | 359 |
|
|
2023
Q4 | $119K | Buy |
881
+63
| +8% | +$8.19K | 0.02% | 266 |
|
|
2023
Q3 | $111K | Buy |
818
+173
| +27% | +$23.6K | 0.02% | 257 |
|
|
2023
Q2 | $92.3K | Sell |
645
-1
| -0.2% | -$147 | 0.01% | 276 |
|
|
2023
Q1 | $89.6K | Buy |
646
+33
| +5% | +$4.44K | 0.02% | 278 |
|
|
2022
Q4 | $83.1K | Buy |
613
+11
| +2% | +$1.38K | 0.02% | 302 |
|
|
2022
Q3 | $66K | Buy |
602
+23
| +4% | +$2.92K | 0.01% | 324 |
|
|
2022
Q2 | $77K | Sell |
579
-101
| -15% | -$13.3K | 0.02% | 303 |
|
|
2022
Q1 | $90K | Buy |
680
+160
| +31% | +$19.2K | 0.02% | 280 |
|
|
2021
Q4 | $61K | Buy |
520
+39
| +8% | +$4.59K | 0.01% | 330 |
|
|
2021
Q3 | $58K | Buy |
481
+150
| +45% | +$17.5K | 0.01% | 328 |
|
|
2021
Q2 | $40K | Buy |
331
+60
| +22% | +$6.58K | 0.01% | 397 |
|
|
2021
Q1 | $27K | Sell |
271
-679
| -71% | -$68.3K | 0.01% | 445 |
|
|
2020
Q4 | $95K | Buy |
950
+274
| +41% | +$29K | 0.02% | 235 |
|
|
2020
Q3 | $74K | Buy |
676
+653
| +2,839% | +$72.6K | 0.02% | 242 |
|
|
2020
Q2 | $2K | Hold |
23
| – | – | ﹤0.01% | 822 |
|
|
2020
Q1 | $2K | Buy |
23
+7
| +44% | +$659 | ﹤0.01% | 674 |
|
|
2019
Q4 | $2K | Buy |
+16
| New | +$1.51K | ﹤0.01% | 726 |
|
|
2018
Q4 | – | Sell |
-122
| Closed | -$10K | – | 779 |
|
|
2018
Q3 | $10K | Buy |
122
+27
| +28% | +$2.04K | ﹤0.01% | 386 |
|
|
2018
Q2 | $7K | Hold |
95
| – | – | ﹤0.01% | 400 |
|
|
2018
Q1 | $7K | Hold |
95
| – | – | ﹤0.01% | 383 |
|
|
2017
Q4 | $7K | Buy |
+95
| New | +$6.41K | ﹤0.01% | 361 |
|
|
2017
Q1 | – | Sell |
-44
| Closed | -$2K | – | 570 |
|
|
2016
Q4 | $2K | Buy |
+44
| New | +$2.5K | ﹤0.01% | 494 |
|
Other funds holding AZN
